JDBRX
Price
$46.81
Change
-$0.47 (-0.99%)
Updated
Jun 13 closing price
Net Assets
26.09B
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

JDBRX vs RLBCX

Header iconJDBRX vs RLBCX Comparison
Open Charts JDBRX vs RLBCXBanner chart's image
Janus Henderson Balanced R
Price$46.81
Change-$0.47 (-0.99%)
VolumeN/A
Net Assets26.09B
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
JDBRX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDBRX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. JDBRX (26.1B). RLBCX pays higher dividends than JDBRX: RLBCX (1.63) vs JDBRX (1.34). JDBRX was incepted earlier than RLBCX: JDBRX (16 years) vs RLBCX (23 years). JDBRX (1.31) is less costly to investors than RLBCX (0.89). JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDBRX: RLBCX (250) vs JDBRX (2500). RLBCX annual gain was more profitable for investors over the last year : 4.94 vs. JDBRX (3.34). JDBRX (38.33) and RLBCX (36.51) have equivalent 5 years return.
JDBRXRLBCXJDBRX / RLBCX
Total Expense Ratio1.310.89147%
Annual Report Gross Expense Ratio1.310.89147%
Fund Existence16 years23 years-
Gain YTD3.8814.29490%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets26.1B244B11%
Annual Yield % from dividends1.341.6382%
Returns for 1 year3.344.9468%
Returns for 3 years32.6431.54104%
Returns for 5 years38.3336.51105%
Returns for 10 years69.9154.99127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd